About
Technology
Issues
FAQ
Links
Official Page
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.